News

Colcrys is a single-ingredient colchicine product, indicated for the prophylaxis and treatment of gout flares, and for the treatment of Familial Mediterranean Fever (FMF). The studies are intended

Currently, the company has started designing a Phase III trial program and protocol to evaluate AmiKet in patients with chemotherapy-induced neuropathic pain (CIPN) to submit the new drug

Nordion provides targeted therapies and sterilization technologies to pharma and biotechnology companies, hospitals, clinics and research laboratories. Nordion will initially implement Pilgrim’s automated Document Management and Change Management

The company’s operating loss for the second quarter of 2011 was $2.99m, compared to $1.35m for the same period in 2010. For the six months ended 30 June

Qcell is an advanced formulation of Coenzyme Q10 (CoQ10) supplement formerly marketed under the brand name Q-Best. Qcell has demonstrated increased absorption rates by up to 10-fold compared

The company has posted a net income of $673,000 for the second quarter of 2011, compared to $1.35m for the same period in 2010. The company’s operating income

Volini Duo, which is developed using advanced Matrix technology, is a bi-layered Acetaminophen tablet, specially formulated to give dual pain relief. Matrix technology allows the regulated release of

The trial is being organized in Australia, Canada, France, the UK and the US under a special protocol assessment (SPA) granted by the US Food and Drug Administration

As per the terms of the agreement, CHDI will fund Isis to identify and conduct IND-enabling studies on an antisense drug targeting the huntingtin gene. Additionally, Isis is